VEERHEALTH CARE LIMITED (VEERHEALTH)

BSE: ₹23.99
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release

The Company wishes to inform that it has received repeat order worth Rs. 3.60 Crores from one of the India's leading FMCG Company and attached is the press release of the same.

2026-06-10 15:26:02
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

The Company wishes to inform about the receipt of order from one of the India's FMCG Company for skin care products for a value of 360 Lakhs.

2026-06-09 16:07:06
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Attached herewith the press release for the audited financial results for March, 2026.

2026-06-02 17:14:42
Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached herewith the newspaper advertisement done today pertaining to audited financial results for March, 2026

2026-06-01 17:42:27
Announcement under Regulation 30 (LODR)-Change in Management

Intimation under regulation 30 for appointment of internal auditor.

2026-05-30 16:26:22
Results For The 31St March, 2026

Enclosed herewith audited financials for 31st march, 2026

2026-05-30 16:22:10
Board Meeting Outcome for Financial Results For March, 2026

Please find attached Audited Financial Results for the quarter and year ended 31st March, 2026.

2026-05-30 13:04:32
Compliances-Reg.24(A)-Annual Secretarial Compliance

Enclosing herewith Annual Secretarial Compliance Report for March, 2026.

2026-05-29 13:01:45
2026-05-25 15:16:28
Announcement under Regulation 30 (LODR)-Press Release / Media Release

We wish to inform you that the Company has received repeat order worth rupees 2.45 crores from one of the India's Leading FMCG Company for Personal Care Products.

2026-05-18 15:56:01

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 3.58 3.83 2.87 3.37 2.06 5.15 3.84 5.62 4.49 3.98 7.26 16.76
YOY Revenue Growth % 25.38% -2.56% 4.16% -9.83% -42.35% 34.46% 33.8% 66.9% 117.25% -22.67% 89.06% 198.25%
Other Income 0.15 0.42 0.24 0.17 0.36 0.25 0.18 0.43 0.65 0.23 -0.29 0.22
Total Income 3.73 4.24 3.11 3.53 2.42 5.39 4.02 6.05 5.14 4.21 6.97 16.98
Total Expenses + 3.32 3.79 2.87 3.38 2.27 4.98 3.95 6.19 4.90 3.87 6.47 16.49
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 0.28 0.31 0.29 0.44 0.32 0.39 0.53 0.34 0.44 0.36 0.47 0.44
Other Expenses 0.57 0.74 0.46 0.43 0.48 1.30 0.51 0.94 0.55 1.03 1.11 1.46
Operating Profit 0.26 0.04 0.00 -0.01 -0.21 0.17 -0.11 -0.57 -0.41 0.11 0.79 0.28
OPM % 7.2% 1% -0.1% -0.2% -10% 3.3% -2.8% -10.1% -9.1% 2.8% 10.9% 1.6%
Profit Before Tax + 0.40 0.45 0.24 0.16 0.15 0.42 0.07 -0.13 0.24 0.34 0.49 0.18
Tax Expense 0.06 0.06 0.04 0.71 0.03 0.12 0.00 -0.03 0.00 0.09 0.09 0.53
Tax % 14.9% 13.3% 18.5% 450% 19.8% 28.7% 0% - 0% 26.3% 18.2% 295.8%
Profit After Tax 0.34 0.39 0.19 -0.55 0.12 0.30 0.07 -0.10 0.24 0.25 0.40 -0.35
EPS (Basic) 0.33 0.19 0.09 -0.26 0.06 0.15 0.04 -0.05 0.12 0.13 0.20 -0.18

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 32.48 16.67 13.22 13.27 9.63 10.58 11.73
YOY Revenue Growth % 94.86% 26.07% -0.38% 37.89% -9.01% -9.79% -
Other Income 0.80 1.22 1.39 1.24 1.67 1.20 0.48
Total Income 33.29 17.89 14.61 14.51 11.29 11.78 12.21
Total Expenses + 31.72 17.38 13.33 13.40 11.06 11.20 11.56
Employee Benefit Expense 1.71 1.58 1.31 0.90 0.88 0.83 0.80
Other Expenses 4.16 3.23 2.17 2.64 2.65 2.17 2.37
Operating Profit 0.77 -0.71 -0.11 -0.12 -1.43 -0.62 0.17
OPM % 2.4% -4.3% -0.8% -0.9% -14.9% -5.9% 1.4%
Profit Before Exceptional 1.57 0.51 1.28 1.12 0.24 0.58 0.65
Exceptional Items -0.31 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 1.26 0.51 1.28 1.12 0.24 0.58 0.65
Tax Expense 0.71 0.12 0.88 -0.47 0.33 0.20 0.33
Tax % 56.8% 22.9% 68.3% -41.6% 140.6% 34.3% 50.8%
Profit After Tax 0.54 0.39 0.41 1.58 -0.10 0.38 0.32
EPS (Basic) 0.27 0.20 0.21 1.52 -0.14 0.55 0.46

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 25.70 22.89 14.66 14.91 13.92 11.89 11.81
Property, Plant & Equipment 23.43 19.87 11.97 12.01 10.54 9.48 9.45
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 18.48 10.88 13.46 10.34 6.23 6.84 6.18
Inventories 4.45 2.44 1.40 2.61 2.12 1.66 1.23
Trade Receivables 9.74 3.21 3.92 1.84 1.54 1.54 0.94
Cash and Cash Equivalents 0.46 1.16 0.24 3.61 0.40 0.10 0.02
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 22.92 22.22 21.84 21.43 13.95 14.04 13.76
Equity Share Capital 20.00 20.00 20.00 10.00 6.93 6.93 6.93
Other Equity 2.92 2.22 1.84 11.43 7.01 7.11 6.82
Non-Current Liabilities 7.80 7.99 3.50 2.85 3.73 3.11 2.73
Current Liabilities 13.45 3.56 2.77 0.97 2.48 1.58 1.49
Total Liabilities 21.25 11.55 6.28 3.82 6.20 4.69 4.23

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 4.19 -0.39 2.90 -0.70 1.81 1.00 0.00
Cash from Investing Activities -4.43 -8.20 -0.28 -1.79 -1.09 -0.09 0.00
Cash from Financing Activities -0.46 9.52 -5.99 5.69 -0.42 -0.83 0.00
Net Increase/Decrease in Cash -0.70 0.92 -3.37 3.21 0.30 0.09 0.00